MA

Mateen Ahmed Ghulam Mustafa

Active Director Director DIN 11097458
DIN 11097458 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mateen Ahmed Ghulam Mustafa

Data last updated:

Mateen Ahmed Ghulam Mustafa is a Director at Humanus Remedium Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11097458
Primary Designation Director
Industry Pharma
First Appointment 08 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20252025Active

Board colleagues of Mateen Ahmed Ghulam Mustafa

NameDINCompanyDesignation
Khalil Ahmed11097459Humanus Remedium Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Humanus Remedium Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mateen Ahmed Ghulam Mustafa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mateen Ahmed Ghulam Mustafa

Mateen Ahmed Ghulam Mustafa currently holds 1 directorship: Humanus Remedium Pharmaceuticals Private Limited (Director, since 08 May 2025).

Mateen Ahmed Ghulam Mustafa was first appointed on 08 May 2025 as Director at Humanus Remedium Pharmaceuticals Private Limited.

The current boards of Mateen Ahmed Ghulam Mustafa's companies include Khalil Ahmed (Humanus Remedium Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available